241 related articles for article (PubMed ID: 8448314)
21. The role of aerosol pentamidine prophylaxis.
Ong EL
Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
[TBL] [Abstract][Full Text] [Related]
22. Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
Kronawitter U; Bogner JR; Goebel FD
Clin Investig; 1992 Dec; 70(12):1089-91. PubMed ID: 1467635
[TBL] [Abstract][Full Text] [Related]
23. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
[TBL] [Abstract][Full Text] [Related]
24. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.
Hirschel B; Lazzarin A; Chopard P; Opravil M; Furrer HJ; Rüttimann S; Vernazza P; Chave JP; Ancarani F; Gabriel V
N Engl J Med; 1991 Apr; 324(16):1079-83. PubMed ID: 2008181
[TBL] [Abstract][Full Text] [Related]
25. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
27. The use of intravenous pentamidine as prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection.
Schroeder KE; Barton SE
Int J STD AIDS; 1994; 5(5):353-5. PubMed ID: 7819354
[TBL] [Abstract][Full Text] [Related]
28. Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia.
Ewig S; Schäfer H; Rockstroh JK; Pickenhain A; Lüderitz B
Eur Respir J; 1996 May; 9(5):1006-12. PubMed ID: 8793464
[TBL] [Abstract][Full Text] [Related]
29. A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis.
Golden JA; Katz MH; Chernoff DN; Duncan SM; Conte JE
Chest; 1993 Sep; 104(3):743-50. PubMed ID: 8365284
[TBL] [Abstract][Full Text] [Related]
30. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
[TBL] [Abstract][Full Text] [Related]
31. Aerosolized pentamidine versus i.v. pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia.
Lidman C; Tynell E; Berglund O; Lindbäck S
Infection; 1993; 21(3):146-9. PubMed ID: 8365811
[TBL] [Abstract][Full Text] [Related]
32. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia.
Ena J; Amador C; Pasquau F; Carbonell C; Benito C; Gutiérrez F; Vilar A
Clin Infect Dis; 1994 Jun; 18(6):901-4. PubMed ID: 8086550
[TBL] [Abstract][Full Text] [Related]
33. Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia.
Turner BJ; Markson L; Cocroft J; Cosler L; Hauck WW
J Gen Intern Med; 1998 Jan; 13(1):16-23. PubMed ID: 9462490
[TBL] [Abstract][Full Text] [Related]
34. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
Teuscher AU; Opravil M; Theiler R; Speich R; Kuster H; Siegenthaler W; Russi EW; Lüthy R
Clin Infect Dis; 1993 Apr; 16(4):519-22. PubMed ID: 8513058
[TBL] [Abstract][Full Text] [Related]
36. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidine.
Principi N; Marchisio P; Onorato J; Gabiano C; Galli L; Caselli D; Morandi B; Campelli A; Clerici M; Gattinara GC
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):158-63. PubMed ID: 8680887
[TBL] [Abstract][Full Text] [Related]
37. Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency.
Casale L; Gold H; Schechter C; Naficy A; Masci JR
Chest; 1993 Feb; 103(2):342-4. PubMed ID: 8094333
[TBL] [Abstract][Full Text] [Related]
38. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity.
Slavin MA; Hoy JF; Stewart K; Pettinger MB; Lucas CR; Kent SJ
AIDS; 1992 Oct; 6(10):1169-74. PubMed ID: 1466849
[TBL] [Abstract][Full Text] [Related]
39. Pneumocystis carinii pneumonia manifested as a hilar mass and cavitary lesion: an atypical presentation in a patient receiving aerosolized pentamidine prophylaxis.
Judson MA; Postic B; Weiman DS
South Med J; 1990 Nov; 83(11):1309-12. PubMed ID: 2237561
[TBL] [Abstract][Full Text] [Related]
40. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial.
Jensen BN; Nielsen TL; Backer V; Nelsing S; Simonsen L; Flaschs H; Gaub J; Højlyng N; Nielsen JO; Mathiesen L
J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):472-7. PubMed ID: 8097788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
